Announcements Trials
Browse Landscape

Status

Recruiting 2No longer available 2Completed 2Terminated 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Tumor-Agnostic 1Thoracic 1

Conditions

Neoplasms 2Granuloma, Plasma Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Crizotinib 2tucatinib 1tazemetostat 1taletrectinib 1nirogacestat 1denileukin diftitox 1copanlisib 1atezolizumab 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × Neoplasms × Crizotinib × Clear all
NCT02473497 2024-06-26

Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients

Pfizer

No longer available
Tumor-Agnostic

Neoplasms

NCT02824094 2017-07-21

Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC

Pfizer

No longer available
Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡